PACB

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +0.18
Percentage change 15.00	%

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG VTI IWM VXF IWN IBB SCHA VTWO VHT

Index	RUT	P/E	-	EPS (ttm)	-2.77	Insider Own	11.97%	Shs Outstand	300.04M	Perf Week	15.00%
Market Cap	414.12M	Forward P/E	-	EPS next Y	-0.54	Insider Trans	-1.23%	Shs Float	264.16M	Perf Month	30.19%
Income	-656.55M	PEG	-	EPS next Q	-0.18	Inst Own	65.68%	Short Float	19.69%	Perf Quarter	11.29%
Sales	152.36M	P/S	2.72	EPS this Y	6.60%	Inst Trans	-12.70%	Short Ratio	5.99	Perf Half Y	-39.21%
Book/sh	0.31	P/B	4.52	EPS next Y	48.13%	ROA	-51.89%	Short Interest	52.02M	Perf Year	-30.30%
Cash/sh	1.15	P/C	1.20	EPS next 5Y	27.48%	ROE	-177.29%	52W Range	0.85 - 2.72	Perf YTD	-24.59%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-23.55%	ROIC	-83.28%	52W High	-49.26%	Beta	2.13
Dividend TTM	-	Quick Ratio	5.87	Sales past 5Y	11.12%	Gross Margin	-230.61%	52W Low	62.14%	ATR (14)	0.11
Dividend Ex-Date	-	Current Ratio	6.68	EPS Y/Y TTM	-100.40%	Oper. Margin	-401.03%	RSI (14)	68.66	Volatility	6.47% 6.93%
Employees	575	Debt/Eq	7.63	Sales Y/Y TTM	-23.99%	Profit Margin	-430.93%	Recom	2.21	Target Price	2.00
Option/Short	Yes / Yes	LT Debt/Eq	7.60	EPS Q/Q	-394.93%	Payout	-	Rel Volume	1.94	Prev Close	1.20
Sales Surprise	4.83%	EPS Surprise	-649.61%	Sales Q/Q	-4.27%	Earnings	May 08 AMC	Avg Volume	8.68M	Price	1.38
SMA20	29.06%	SMA50	21.71%	SMA200	-12.49%	Trades		Volume	16,678,632	Change	15.00%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
10:00AM	Loading…
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Loading…
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)
Apr-04-25 07:45PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +7.32%
Mar-27-25 09:05AM	Jim Gibson to join PacBio as Chief Financial Officer (GlobeNewswire)
Mar-20-25 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
01:05PM	Loading…
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
Mar-18-25 06:15PM	Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? (Insider Monkey)
05:08AM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
Mar-17-25 09:05AM	Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes (GlobeNewswire)
05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-14-25 06:15PM	Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Mar-11-25 09:01AM	1 Healthcare Stock to Target This Week and 2 to Turn Down (StockStory) -5.76%
Feb-19-25 04:05PM	PacBio to Participate in TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -5.35% -7.34%
Feb-15-25 11:02AM	PacBio should return to growth over time, says Canaccord (TipRanks)
Feb-14-25 11:09PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +25.00%
02:21AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Feb-13-25 06:00PM	Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics (Zacks) +8.82%
05:20PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:13PM	PacBio (NASDAQ:PACB) Misses Q4 Sales Targets (StockStory)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 08:03AM	PacBio (PACB) Q4 Earnings Report Preview: What To Look For (StockStory)
07:42AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why (Zacks) +13.89%
Feb-03-25 09:05AM	PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service (GlobeNewswire) -5.19%
Jan-30-25 04:05PM	PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 (GlobeNewswire)
09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 09:05AM	PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics (GlobeNewswire)
Jan-27-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know (Zacks)
Jan-24-25 09:16AM	PacBio announces GIFS at USask as first Revio PacBio CSP in Canada (TipRanks)
Jan-23-25 09:05AM	PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider (GlobeNewswire) -8.84%
Jan-14-25 09:05AM	PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics (GlobeNewswire) -7.96%
09:00AM	PacBio Announces Preliminary Fourth Quarter and Full Year Revenue (GlobeNewswire)
Jan-10-25 06:05AM	PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing (GlobeNewswire)
Jan-08-25 09:05AM	PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets (GlobeNewswire)
Jan-07-25 06:15PM	Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today (Zacks)
11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-02-25 04:05PM	PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.56%
Dec-30-24 03:03PM	Why Is Pacific Biosciences of California, Inc. (PACB) Among the Top CRISPR Stocks to Invest In? (Insider Monkey)
Dec-11-24 11:50AM	Why Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey)
Nov-19-24 07:01PM	Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +9.55%
Nov-12-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) -10.37%
Nov-08-24 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.12% +6.96%
06:03AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 07:30PM	Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -7.55%
06:15PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
05:14PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Third Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 (GlobeNewswire)
Nov-06-24 10:35PM	PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop (GlobeNewswire)
07:30AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-24 09:16AM	Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Oct-31-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks) +12.44%
Oct-30-24 02:57PM	Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology (Insider Monkey)
10:13AM	Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep (PR Newswire)
Oct-29-24 09:05AM	PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500 (GlobeNewswire) +11.96%
Oct-22-24 09:05AM	PacBio Onso Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program (GlobeNewswire)
Oct-16-24 06:15PM	Pacific Biosciences of California (PACB) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks) -7.77%
Oct-11-24 09:05AM	PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing (GlobeNewswire) +27.74%
Oct-10-24 04:05PM	PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-01-24 09:05AM	PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore (GlobeNewswire)
Sep-27-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
04:05PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire)
Sep-13-24 06:15PM	Pacific Biosciences of California (PACB) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Sep-11-24 12:38PM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
09:05AM	PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific (GlobeNewswire)
Sep-08-24 04:51PM	Pacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Sep-04-24 09:05AM	Revio to Power Research in Male Infertility and Rare Disease at Munster University Hospital (GlobeNewswire)
09:05AM	Revio to Power Research in Male Infertility and Rare Disease at M nster University Hospital (GlobeNewswire)
Aug-26-24 04:03PM	PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire) -8.13%
Aug-12-24 12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks) -10.06%
Aug-08-24 12:09PM	PacBio (PACB) Q2 Earnings Beat Estimates, Revenues Down Y/Y (Zacks) +9.15%
Aug-07-24 07:30PM	Compared to Estimates, Pacific Biosciences (PACB) Q2 Earnings: A Look at Key Metrics (Zacks)
07:15PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue Estimates (Zacks)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM
Eidel Jeff	See Remarks	Aug 19 '24	Sale	1.59	26,760	42,602	869,730	Aug 20 05:27 PM
Van Oene Mark	See Remarks	Aug 16 '24	Sale	1.66	38,011	63,174	1,630,815	Aug 20 05:25 PM
JEFFREY EIDEL	Officer	Aug 19 '24	Proposed Sale	1.59	26,760	42,589		Aug 19 04:24 PM
MARK VAN OENE	Officer	Aug 16 '24	Proposed Sale	1.66	38,011	63,189		Aug 16 04:29 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Pacific Biosciences of California Inc

Upgrade your FINVIZ experience